Press Releases

Toronto, Ontario – September 12, 2023– Predictmedix AI Inc.  (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP) (the “Company” or “Predictmedix”) is proud to announce its recent feature in the prestigious Toronto Star newspaper, accompanied by a compelling interview with the company’s COO, Dr. Rahul Kushwah. This exciting development marks a significant milestone in Predictmedix’s journey, enhancing the […]

Predictmedix AI’s 2023 Breakthroughs: Pioneering Healthcare Innovation and Global Expansion   Toronto, Ontario – September 6, 2023– Predictmedix AI Inc.  (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP) (the “Company” or “Predictmedix”) today provided an update on its achievements and developments so far in 2023. Predictmedix AI, a leader in AI-driven healthcare solutions, has achieved remarkable milestones and […]

Toronto, Ontario – August 21, 2023– Predictmedix AI Inc.  (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP) (the “Company” or “Predictmedix”) today announced a recent technological milestone in its AI product suite – the ability to detect early signs of diabetes in individuals by analyzing subtle biological indicators, often undetected by conventional methods. Predictmedix AI’s expansion into diabetic […]

Toronto, Ontario – August 10 2023– Predictmedix AI Inc.  (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP) (the “Company” or “Predictmedix”) today provided an update on its Safe Entry Stations as it relates to the healthcare vertical in which the company is rapidly commercializing into. Safe Entry was featured in an independent newspaper article in India focused on […]

Toronto, Ontario – August 2, 2023– Predictmedix AI Inc.  (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP) (the “Company” or “Predictmedix”) is pleased to announce a significant milestone, having completed over 200,000 individual scans through its AI-powered Safe Entry Stations covering various vitals such as body temperature, heart rate, respiration rate, body weight, HRV, fatigue, and impairment. This […]

Toronto, Ontario, July 28, 2023 – Predictmedix Inc. (“Predictmedix” or the “Company”) (CSE: PMED) (OTCQB: PMEDF) (FRA: 3QP), a leading provider of rapid health screening solutions powered by proprietary artificial intelligence (AI), is pleased to announce significant progress in its commercialization roadmap to integrate Safe Entry Stations (SES) into the Indonesian healthcare sector. Through a […]

Toronto, Ontario – July 25, 2023– Predictmedix AI Inc.  (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP) (the “Company” or “Predictmedix”) is pleased to announce that its fully owned Indian subsidiary, Predictmedix India Private Ltd has engaged with a prominent Indian supplier for the mass production of the Company’s AI-powered Safe Entry Stations. The prominent supplier has worked […]

Toronto, Ontario – July 19, 2023– Predictmedix AI Inc.  (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP) (the “Company” or “Predictmedix“) is proud to announce its ground-breaking contactless integrative AI solutions for healthcare, poised to revolutionize the industry in India. Leveraging the power of advanced AI algorithms and state-of-the-art technology, Predictmedix aims to enhance the efficiency, accuracy, and […]

Toronto, Ontario – (July 13, 2023) – Predictmedix Inc.  (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP) (the “Company” or “Predictmedix“) is pleased to announce that it has completed its name change from “Predictmedix Inc.” to “Predictmedix AI Inc.” (the “Name Change“). The articles of the Company provide the directors with the authority to change the name of […]

Toronto, Ontario, July 10, 2023 – Predictmedix (“Predictmedix” or the “Company”) (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP), a leading provider of rapid health screening solutions powered by proprietary artificial intelligence (AI), announced today that it will be changing its corporate name to Predictmedix AI Inc, aligning the company’s brand image with its innovative and AI-driven approach […]

Toronto, Ontario, June 21, 2023 – Predictmedix Inc. (“Predictmedix” or the “Company”) (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP), a leading provider of rapid health screening solutions powered by proprietary artificial intelligence (AI), announces the closing of its previously announced private placement. The Company has issued 10,510,000 units (the “Units”) at a price of $0.10 per unit […]

  Key ongoing discussions with Government officials for scaling Safe Entry’s multiple healthcare applications Ongoing partnership with prestigious Indonesian university for validation of Safe Entry as part of medical device regulatory approval process Significant updates to Safe Entry’s technology suite and broad healthcare applications   Toronto, Ontario – June 13, 2023 – Predictmedix Inc. (“Predictmedix” […]